Cargando…
Targeting macrophages in atherosclerosis using nanocarriers loaded with liver X receptor agonists: A narrow review
Macrophages are involved in the whole process of atherosclerosis, which is characterized by accumulation of lipid and inflammation. Presently, clinically used lipid-lowering drugs cannot completely retard the progress of atherosclerosis. Liver X receptor (LXR) plays a key role in regulation of lipid...
Autores principales: | Yang, Tong-Mei, Miao, Miao, Yu, Wen-Qian, Wang, Xue, Xia, Fang-Jie, Li, Yan-Jie, Guo, Shou-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018149/ https://www.ncbi.nlm.nih.gov/pubmed/36936982 http://dx.doi.org/10.3389/fmolb.2023.1147699 |
Ejemplares similares
-
Macrophage Plasticity and Atherosclerosis Therapy
por: Lin, Ping, et al.
Publicado: (2021) -
Mechanism of Peptide Agonist Binding in CXCR4 Chemokine Receptor
por: Pawnikar, Shristi, et al.
Publicado: (2022) -
Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis
por: Zhang, Bai-Hui, et al.
Publicado: (2022) -
The Cordyceps militaris-Derived Polysaccharide CM1 Alleviates Atherosclerosis in LDLR((-/-)) Mice by Improving Hyperlipidemia
por: Yin, Fan, et al.
Publicado: (2021) -
Nanogels as novel drug nanocarriers for CNS drug delivery
por: Manimaran, V., et al.
Publicado: (2023)